Literature DB >> 22196979

Surgical margins for melanoma in situ.

Joy H Kunishige1, David G Brodland, John A Zitelli.   

Abstract

BACKGROUND: A controversy in the treatment of melanoma in situ is the required width of surgical margin. The currently accepted 5-mm margin is based on a 1992 consensus opinion, despite data since then showing this is inadequate.
OBJECTIVE: We sought to develop guidelines for predetermined surgical margins for excision of melanoma in situ.
METHODS: A prospectively collected series of 1072 patients with 1120 melanoma in situs was studied. All lesions were excised by Mohs micrographic surgery with frozen-section examination of the margin. The minimal surgical margin was 6 mm, and the total margin was calculated by adding an additional 3 mm for each subsequent stage required. The minimum surgical margin that would successfully remove 97% of all tumors was calculated. Local recurrence was also tabulated.
RESULTS: In all, 86% of melanoma in situs were successfully excised with a 6-mm margin; 9 mm removed 98.9% of melanoma in situs. The superiority of 9-mm to 6-mm margins was significant (P < .001). Gender, location, and diameter did not affect results. Recurrence rate for this set of patients treated with Mohs micrographic surgery was 0.3% (n = 3). LIMITATIONS: Margins less than 6 mm were not studied. This is a referral center for melanoma in situ and 10% of tumors were previously treated before presentation to our clinic.
CONCLUSION: The frequently recommended 5-mm margin for melanoma is inadequate. Standard surgical excision of melanoma in situ should include 9 mm of normal-appearing skin, similar to that recommended for early invasive melanoma.
Copyright © 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22196979     DOI: 10.1016/j.jaad.2011.06.019

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  28 in total

Review 1.  Diagnosis and Management of Acral Lentiginous Melanoma.

Authors:  Yoshiyuki Nakamura; Yasuhiro Fujisawa
Journal:  Curr Treat Options Oncol       Date:  2018-06-27

Review 2.  A surgical perspective report on melanoma management.

Authors:  Brian D Wernick; Neha Goel; Francis Sw Zih; Jeffrey M Farma
Journal:  Melanoma Manag       Date:  2017-05-15

Review 3.  Lentigo maligna and lentigo maligna melanoma: contemporary issues in diagnosis and management.

Authors:  Karen L Connolly; Kishwer S Nehal; Klaus J Busam
Journal:  Melanoma Manag       Date:  2015-05-18

4.  Treatment of Head and Neck Melanoma In Situ With Staged Contoured Marginal Excisions.

Authors:  Evan S Glazer; Caitlin F Porubsky; Jeffrey D Francis; Jamie Ibanez; Nicholas Castner; Jane L Messina; Amod A Sarnaik; Michael A Harrington; C Wayne Cruse; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Plast Surg       Date:  2017-06       Impact factor: 1.539

5.  Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.

Authors:  Adi Nosrati; Jacqueline G Berliner; Shilpa Goel; Joseph McGuire; Vera Morhenn; Juliana R de Souza; Yildiray Yeniay; Rasnik Singh; Kristina Lee; Mio Nakamura; Rachel R Wu; Ann Griffin; Barbara Grimes; Eleni Linos; Mary Margaret Chren; Roy Grekin; Maria L Wei
Journal:  JAMA Dermatol       Date:  2017-05-01       Impact factor: 10.282

6.  Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.

Authors:  Sheila M Valentín-Nogueras; David G Brodland; John A Zitelli; Lorena González-Sepúlveda; Cruz M Nazario
Journal:  Dermatol Surg       Date:  2016-06       Impact factor: 3.398

7.  Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline.

Authors:  F C Wright; L H Souter; S Kellett; A Easson; C Murray; J Toye; D McCready; C Nessim; D Ghazarian; N J Look Hong; S Johnson; D P Goldstein; T Petrella
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

Review 8.  Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma--Part I.

Authors:  Luiz Guilherme Martins Castro; Maria Cristina Messina; Walter Loureiro; Ricardo Silvestre Macarenco; João Pedreira Duprat Neto; Thais Helena Bello Di Giacomo; Flávia Vasques Bittencourt; Renato Marchiori Bakos; Sérgio Schrader Serpa; Hamilton Ometto Stolf; Gabriel Gontijo
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

9.  Melanoma in Situ Treated with Topical Imiquimod for Management of Persistently Positive Margins: A Review of Treatment Methods.

Authors:  Qing Fan; Stephanie Cohen; Becky John; Adam I Riker
Journal:  Ochsner J       Date:  2015

10.  Correlation Between Appropriate Use Criteria and the Frequency of Subclinical Spread or Reconstruction With a Flap or Graft for Melanomas Treated With Mohs Surgery With Melanoma Antigen Recognized by T Cells 1 Immunostaining.

Authors:  Jeremy R Etzkorn; Joseph F Sobanko; Thuzar M Shin; Rosalie Elenitsas; Emily Y Chu; Joel M Gelfand; David J Margolis; Jason G Newman; Hayley Goldbach; Christopher J Miller
Journal:  Dermatol Surg       Date:  2016-04       Impact factor: 3.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.